Bio Pharma Services and ADA Medical in Collaboration
News Feb 21, 2014
Biopharma Services Inc. has announced that in collaboration with its sister company, ADA Medical Ltd., it can now offer a complete range of contract research services, from early pre-clinical drug development through to Phase I - IV clinical trials.
“ADA Medical’s pre-clinical drug development research services and late stage Phases IIb - IV medical research are a natural fit with Biopharma Services Inc. early stage Phases I - IIa” commented Renzo DiCarlo, CEO of Biopharma Services Inc. and ADA Medical Ltd.
ADA Medical’s existing project management skills coupled with Biopharma’s pharmacodynamics, pharmacokinetics, biostatistics, data management, regulatory and quality assurance capabilities bring the needed management and quality oversight to create the discipline needed for drug research and clinical trials.
A form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. During a meeting at the US Food and Drug Administration (FDA) in Silver Spring, Maryland, an independent advisory panel voted 14-2 in favor of recommending a compound known as esketamine for use in treating depression.READ MORE